- Home
- Labeler Index
- Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc
- 0955-2900
- NDC Crossover: 0955-2900 Insulin Glargine U-300 Max
NDC Crossover 0955-2900 Insulin Glargine U-300 Max
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
Explore similar products and medications to NDC 0955-2900 Insulin Glargine U-300 Max a human prescription drug with other products crossover matching the same product name (Insulin Glargine U-300 Max) or generic name (Insulin Glargine), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0024-5869 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 0024-5871 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 0955-3900 | Insulin Glargine U-300 | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 50090-2193 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
| 50090-4177 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |